haemolysis in context of disease

Schedule Overview

Today’s lecture focuses on understanding biochemistry processes related to haemolysis, specifically in the context of various diseases affecting haemoglobin structure and function, such as hereditary spherocytosis and paroxysmal nocturnal haemoglobinuria. The goal is to equip you with knowledge that will aid in dissection of case studies in the upcoming academic year.

Hemolysis

Concepts of Hemolysis

  1. Extravascular Hemolysis

  2. Intravascular Hemolysis

  3. Key Markers: Understanding necessary markers for effective diagnosis and patient management.

    • Preparation for potential case studies.

Review of Hemoglobin Structure

Structure of Hemoglobin

  • Emphasis on revisiting hemoglobin structure as it was covered previously at Level 4.

  • For Level 5, a deeper approach is critical, focusing on a holistic breakdown of hemoglobin structure into four major components:

    1. Primary Structure

    • Sequence of amino acids.

    1. Secondary Structure

    • Formation of alpha helices.

    1. Tertiary Structure

    • Three-dimensional shape formed by interactions among non-helical areas.

    1. Quaternary Structure

    • How multiple globin chains interact.

Historical Perspective

  • Max Perutz illustrated hemoglobin structure using X-ray crystallography, helping us understand its complexity.

Components of Hemoglobin

Composition of Hemoglobin

  • Hemoglobin consists of four globin chains, usually two alpha (α) and two beta (β) chains, forming Hemoglobin A (HbA).

  • Minor components include:

    • Hemoglobin A2 (HbA2): Composed of two alpha and two delta chains, constituting about 2-3% of total hemoglobin.

    • Fetal Hemoglobin (HbF): Composed of two alpha and two gamma chains, offering protective effects against sickling in sickle cell disease.

Genetic Basis of Hemoglobin Chains

  • Alpha Chains: Located on chromosome 16; four genes in total (two pairs).

  • Beta Chains: Located on chromosome 11; encodes for the beta globin gene and multiple regulatory genes.

  • Zeta Chains: Primitive fetal chains that transition to alpha chains after fetal development.

Structural Levels of Hemoglobin

Primary Structure

  • Detailed description of amino acid sequences:

    • Alpha chains consist of 141 amino acids.

    • Beta chains consist of 146 amino acids.

Secondary Structure

  • Predominantly characterized by alpha helices (8 helices per globin chain).

  • Structural nomenclature includes regions between helices to denote non-helical areas.

Tertiary Structure

  • 3D folding pattern influenced by interactions between hydrophobic and polar amino acids.

    • Polar residues (e.g., glutamate) orient to exterior and hydrophobic (e.g., valine) to interior to protect heme.

  • Heme attached in a hydrophobic environment to mitigate oxidation of iron.

Quaternary Structure

  • Interaction of alpha and beta chains at junction points, impacting function and stability of hemoglobin molecule.

  • Rigidity and flexibility of junctions support oxygen binding efficiency and facilitated oxygen transfer under physiological conditions.

Implications of Hemoglobin Mutations

Clinical Conditions

  1. Sickle Cell Disease: Elevated HbF levels can reduce incidence of sickling crises.

  2. Hemoglobinopathies: Variants in hemoglobin structure (e.g., HbC mutation) can lead to instability and hemolytic anemia.

  3. Thalassemia: A reduction in production of one of the globin chains; divided into alpha and beta types.

Types of Hemoglobinopathies

  • Alpha Thalassemia: Characterized by deletions of alpha globin genes. Types include:

    • Four gene deletions (incompatible with life).

    • Three gene deletions (Hemoglobin H disease).

    • Two and one gene deletions (asymptomatic).

  • Beta Thalassemia: More complex with over 80 variants segregated based on location and mutation, leading to different clinical presentations.

Diagnosis and Management

Diagnostic Techniques

  • Utilize HPLC and electrophoresis for blood samples to identify hemoglobin types and assess conditions.

    • Differentiation between iron deficiency anemia and thalassemia requests careful evaluation of ferritin and hemoglobin levels.

Treatment Approaches

  1. Iron Overload Management: For patients receiving repeated transfusions.

  2. Genetic Counseling: Especially for families with a history of thalassemia.

  3. Potential Cures: Stem cell transplantation and gene therapy emerging as curative approaches, but complexities remain.

Ethical Considerations

  • Future discussions surrounding genetic manipulation and designer babies raising moral and ethical dilemmas regarding thalassemia prevention and cure.

Conclusion

  • The understanding of hemoglobin structure, associated mutations, and hemolytic anemias will be vital as we progress in clinical applications and patient management strategies. The subsequent sessions will further explore hemolysis in depth, focusing on laboratory approaches and clinical case studies.